I am a breastfeeding mother and i want to know if it is safe to use Ethinylestradiol + Norelgestromin? Is Ethinylestradiol + Norelgestromin safe for nursing mother and child? Does Ethinylestradiol + Norelgestromin extracts into breast milk? Does Ethinylestradiol + Norelgestromin has any long term or short term side effects on infants? Can Ethinylestradiol + Norelgestromin influence milk supply or can Ethinylestradiol + Norelgestromin decrease milk supply in lactating mothers?

- DrLact safety Score for Ethinylestradiol + Norelgestromin is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Ethinylestradiol + Norelgestromin may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Ethinylestradiol + Norelgestromin may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Ethinylestradiol + Norelgestromin low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Ethinylestradiol + Norelgestromin We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Combined contraceptive pill that contains estrogen (ethinyl estradiol) and progestin (norelgestromin) for use as transdermal patch (treatment duration 3 weeks). Ethinylestradiol is a synthetic estrogen with similar action than estradiol. Used in combination with progestogens for contraception.Ethinylestradiol is excreted into the breast milk in no or small amount.There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of ethinyl estradiol.It may reduce the protein content of the milk.No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. Norelgestromin is the active metabolite of norgestimate, which is structurally similar to levonorgestrel. It is used as a contraceptive drug in combination with ethinyl estradiol. At latest update no published data on excretion into breast milk were found. With other similar combined contraceptives no differences have been observed in the frequency of breastfeeding or the amount of milk produced or weight gain of breastfed infants compared to other contraceptive methods (intrauterine devices, isolated progestogens). However, it would be advisable to avoid them until breastfeeding is well established (4-6 weeks). During lactation, progestin-only contraceptive pills are preferred to Estrogen containing ones, otherwise, the lowest estrogen dose should be used.During the first 6 postpartum weeks, non-hormonal methods are in the first line of choice. Hormone containing contraceptives do not affect the composition of milk, minerals (Mg, Fe, Cu, Ca, P) fat, lactose and calories but only a few the proteins.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.